EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR-Cas9 guided rna based model for the treatment of Amyotrophic Lateral Sclerosis: A progressive neurodegenerative disorder

Muhammad Naveed, Muhammad Aqib Shabbir, Tariq Aziz, Hafiz Muhammad Hurraira, Sayyeda Fatima Zaidi, Ramsha Athar, Hassan Anwer Chattha, Metab Alharbi, Abdulrahman Alshammari, Abdullah F Alasmari

Acta Biochimica Polonica · 2023

DOI: 10.18388/abp.2020_6789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica Polonica, 2023. Verfasst von Muhammad Naveed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore Pakistan. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that leads to the degeneration of motor neurons and the weakening of muscles. Despite extensive research efforts, there is currently no cure for ALS and existing treatments only address its symptoms. To address this unmet medical need, genome editing technologies, such as CRISPR-Cas9, have emerged as a promising solution for the development of new treatments for ALS. Studies have shown that CRISPR-Cas9-guided RNAs have the potential to provide accurate and effective silencing in the genetic disease of ALS. Results have demonstrated a 67% on-target score and a 98% off-target score with GC content within the range of 40–60%. This is further validated by the correlation between the gRNA’s structural accuracy and the minimum free energy. The use of CRISPR-Cas9 provides a unique opportunity to target this disease at the molecular level, offering hope for the development of a more effective treatment. In silico and computational therapeutic approaches for ALS suggest that the CRISPR-Cas9 protein holds promise as a future treatment candidate. The CRISPR mechanism and the specificity of gRNA provide a novel therapeutic approach for this genetic disease, offering new hope to those affected by ALS. This study highlights the potential of CRISPR-Cas9 as a promising solution for the development of new treatments for ALS. Further research is required to validate these findings in preclinical and clinical trials and to establish the safety and efficacy of this approach in the treatment of ALS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisHumansCRISPR-Cas SystemsGene EditingMusclesRNA, Guide, CRISPR-Cas Systems

Substanzen

RNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore Pakistan.
  • Department of Agriculture University of Ioannina Arta 47100 Greece.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.

Zitieren

APA

Naveed, M., Aqib Shabbir, M., Aziz, T., Hurraira, H. M., Fatima Zaidi, S., Athar, R., Chattha, H. A., Alharbi, M., Alshammari, A., & Alasmari, A. F. (2023). CRISPR-Cas9 guided rna based model for the treatment of Amyotrophic Lateral Sclerosis: A progressive neurodegenerative disorder. Acta Biochimica Polonica. https://doi.org/10.18388/abp.2020_6789

Vancouver

Naveed M, Aqib Shabbir M, Aziz T, Hurraira HM, Fatima Zaidi S, Athar R, et al. CRISPR-Cas9 guided rna based model for the treatment of Amyotrophic Lateral Sclerosis: A progressive neurodegenerative disorder. Acta Biochimica Polonica. 2023. doi:10.18388/abp.2020_6789

BibTeX
@article{Naveed2023,
  author = {Naveed, Muhammad and Aqib Shabbir, Muhammad and Aziz, Tariq and Hurraira, Hafiz Muhammad and Fatima Zaidi, Sayyeda and Athar, Ramsha and Chattha, Hassan Anwer and Alharbi, Metab and Alshammari, Abdulrahman and Alasmari, Abdullah F},
  title = {CRISPR-Cas9 guided rna based model for the treatment of Amyotrophic Lateral Sclerosis: A progressive neurodegenerative disorder},
  journal = {Acta Biochimica Polonica},
  year = {2023},
  doi = {10.18388/abp.2020_6789}
}
Kostenlos starten →